Rinvoq ER 30 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FQR9E
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,767
Award facts
- Contract value 100% obligated
- $36,767.19 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,767.19 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on December 10, 2025, with completion targeted for December 11, 2025. This firm fixed price delivery order represents a non-competitive, non-set-aside award to the prime contractor under its existing Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and supplies an extensive range of brand-name and generic medications, vaccines, and medical devices to support military and veteran healthcare systems nationwide.
This delivery order falls under AmerisourceBergen's broader $999,999,999 IDC with DLA Troop Support Medical (designated SPE2DX), which extends through December 2026 and functions as a comprehensive global pharmaceutical support vehicle. The contract enables the distributor to supply critical medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. RINVOQ is a targeted synthetic immunosuppressant used in the treatment of rheumatoid arthritis and other inflammatory conditions, representing the type of specialized pharmaceutical products AmerisourceBergen delivers through its federal contract portfolio.
Quick answers
Who was awarded contract SPE2DR26FQR9E?
SPE2DR26FQR9E was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 10, 2025.
How much is contract SPE2DR26FQR9E worth?
The government has obligated $36,767 on SPE2DR26FQR9E.
Is contract SPE2DR26FQR9E an order under another contract?
Yes. SPE2DR26FQR9E is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQR9E competed?
The extent of competition for SPE2DR26FQR9E was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award